RA2's Phase 3 Drug Pipeline Analysis

RA2's Phase 3 Drug Pipeline Analysis

An analysis of the Alzheimer's drugs in Phase 3 clinical trials

RA2 Pipeline Report
Will the next five years witness an innovation wave in medicines for Alzheimer's?


Growing Optimism that Promising Alzheimer’s Medicines Will Emerge During the Next Five Years
Read the press release.


Sign up for Alzheimer's Talks
On Monday, April 11, from 4 to 5 p.m. ET, we will discuss the exciting new analysis published by ResearchersAgainstAlzheimer’s, an UsAgainstAlzheimer’s network.